CHNA

Loncar China BioPharma ETF

Delisted

CHNA was delisted on the 20th of October, 2023.

4 hedge funds and large institutions have $920K invested in Loncar China BioPharma ETF in 2021 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
4
Holders Change
-3
Holders Change %
-42.86%
% of All Funds
0.07%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
2
Reduced
1
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
Jane Street
1
Jane Street
New York
$773K -$753K -20,410 -49%
Morgan Stanley
2
Morgan Stanley
New York
$81K +$6.96K +188 +9%
UBS Group
3
UBS Group
Switzerland
$62K +$47.6K +1,291 +331%
Royal Bank of Canada
4
Royal Bank of Canada
Ontario, Canada
$4K +$4K +100 New
Citadel Advisors
5
Citadel Advisors
Florida
-$346K -10,621 Closed
FEM
6
Fulcrum Equity Management
Texas
-$326K -10,023 Closed
Osaic Holdings
7
Osaic Holdings
Arizona
-$23K -719 Closed